Home
About
Overview
Sharing Data
ORCID
Help
History (109)
Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta.
The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.
Genetic and epigenetic regulation in nuclear microenvironments for biological control in cancer.
Measuring outcomes--what's meaningful?
See All 109 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Measuring outcomes--what's meaningful?
Fain JA. Measuring outcomes--what's meaningful? Diabetes Educ. 2000 Jan-Feb; 26(1):13.
View in:
PubMed
subject areas
Diabetes Mellitus
Humans
Patient Education as Topic
Quality Indicators, Health Care
Societies, Scientific
Total Quality Management
United States
authors with profiles
James Allen Fain PhD, RN, BC-ADM, FAAN